| Literature DB >> 11883957 |
Hiroki Kano1, Kazuhiro Kobayashi, Ralf Herrmann, Masaji Tachikawa, Hiroshi Manya, Ichizo Nishino, Ikuya Nonaka, Volker Straub, Beril Talim, Thomas Voit, Haluk Topaloglu, Tamao Endo, Hideki Yoshikawa, Tatsushi Toda.
Abstract
Alpha-dystroglycan is a component of the dystrophin-glycoprotein-complex, which is the major mechanism of attachment between the cytoskeleton and the extracellular matrix. Muscle-eye-brain disease (MEB) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities and lissencephaly. We recently found that MEB is caused by mutations in the protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase (POMGnT1) gene. POMGnT1 is a glycosylation enzyme that participates in the synthesis of O-mannosyl glycan, a modification that is rare in mammals but is known to be a laminin-binding ligand of alpha-dystroglycan. Here we report a selective deficiency of alpha-dystroglycan in MEB patients. This finding suggests that alpha-dystroglycan is a potential target of POMGnT1 and that altered glycosylation of alpha-dystroglycan may play a critical role in the pathomechanism of MEB and some forms of muscular dystrophy. (C)2002 Elsevier Science (USA).Entities:
Mesh:
Substances:
Year: 2002 PMID: 11883957 DOI: 10.1006/bbrc.2002.6608
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575